+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis: A Sequential Analysis of Randomized Controlled Trials



Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis: A Sequential Analysis of Randomized Controlled Trials



Journal of Clinical Gastroenterology 50(10): 871-881



Despite the significant morbidity and mortality associated with alcoholic hepatitis, a consensus or generally accepted therapeutic strategy has not yet been reached. The purpose of this analysis was to evaluate the effects of corticosteroids and pentoxifylline on short-term mortality, incidence of hepatorenal syndrome, and sepsis in patients with severe alcoholic hepatitis. We conducted a comprehensive search of the Cochrane library, PUBMED, Scopus, EMBASE, and published proceedings from major hepatology and gastrointestinal meetings from January 1970 to June 2015. All relevant articles irrespective of language, year of publication, type of publication, or publication status were included. Two independent reviewers extracted data and scored publications; a third investigator adjudicated discrepancies. The κ scores were measured to assess the agreement between the 2 initial reviewers. The review and meta-analyses were performed following the recommendations of The Cochrane Collaboration. Conventional meta-analysis and Trial sequential analysis were performed. GRADEpro version 3.6 was used to appraise the quality of epidemiologic evidence. A total of 14 studies satisfied inclusion criteria comparing corticosteroids, pentoxifylline, or placebo. Compared with placebo, corticosteroids reduced 28-day mortality (RR=0.53; 95% CI, 0.33-0.84; P=0.006). There was no statistically significant difference in short-term mortality between pentoxifylline and placebo (RR=0.74; 95% CI, 0.46-1.18; P=0.21). Neither corticosteroids nor pentoxifylline impacted the incidence of hepatorenal syndrome or sepsis. Trial sequential analysis confirmed the results of our conventional meta-analysis. Corticosteroids demonstrated a decrease in 28-day mortality in patients with severe alcoholic hepatitis. The evidence from this study is insufficient to support any recommendations regarding the mortality benefit of pentoxifylline in severe alcoholic hepatitis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057525910

Download citation: RISBibTeXText

PMID: 27404293

DOI: 10.1097/mcg.0000000000000585


Related references

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. Journal of Hepatology 36(4): 480-487, 2002

Pentoxifylline Plus Prednisolone versus Pentoxifylline Only for Severe Alcoholic Hepatitis: A Randomized Controlled Clinical Trial. Annals of Medical and Health Sciences Research 4(5): 810-816, 2014

Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials. Gastroenterology 155(2): 458-468.E8, 2018

Corticosteroids efficacy in severe alcoholic hepatitis Retrospective analysis of individual data from the American and French randomized controlled trials. Gastroenterology 118(4 Suppl 2 Part 1): AASLD A972, 2000

Pentoxifylline Does Not Improve Short-Term Survival In Severe Alcoholic Hepatitis In Combination With Corticosteroids: Results Of A Randomized Controlled Trial. Journal of Hepatology 56: S533-S534, 2012

Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial. World Journal of Gastroenterology 15(13): 1613-1619, 2009

Corticosteroids decrease short term mortality in patients with severe alcoholic hepatitis Individual data meta-analysis of the last three randomized placebo controlled double blind trials. Hepatology 32(4 Pt 2): 419A, 2000

Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials. Liver International 36(5): 721-728, 2017

Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis A randomized trial. Hepatology 34(4 Pt 2): 250A, 2001

Treatment of severe alcoholic hepatitis with corticosteroids and pentoxifylline. JAMA 310(10): 1029-1030, 2013

Corticosteroids reduce mortality from alcoholic hepatitis in patients without encephalopathy a meta analysis of the randomized trials rcts including french trials. Hepatology 14(4 Part 2): 234A, 1991

Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. Annals of Internal Medicine 113(4): 299-307, 1990

Corticosteroids reduce mortality from alcoholic hepatitis a meta analysis of the randomized trials. Hepatology 10(4): 580, 1989

Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis. Indian Journal of Gastroenterology 2018, 2018

Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. Journal of Hepatology 48(3): 465-470, 2008